Compare Novartis AG (NVS) vs Weibo Corp (WB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Weibo Corp — how do they compare? Novartis AG trades at $152.33 (market cap $295.37B), while Weibo Corp trades at $7.77 (market cap $1.93B). The key difference: Novartis AG is far larger — about 153× Weibo Corp's market cap, and Weibo Corp pays the higher dividend (7.75%). Which is the better fit depends on your goals.
| NVS | WB | |
|---|---|---|
Market Cap | $295.37B | $1.93B |
Sector | Health | Media |
52-Week High | $168.62 | $12.83 |
52-Week Low | $119.31 | $7.20 |
Enterprise Value | $336.69B | $1.20B |
Dividend Yield | 3.07% | 7.75% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Weibo Corp
Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →
